Frankfurt - Delayed Quote EUR
MetLife, Inc. (MWZ.F)
67.82
-1.25
(-1.81%)
At close: May 23 at 9:40:45 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 6 |
| Avg. Estimate | 18.35B | 18.53B | 75.02B | 77.7B |
| Low Estimate | 17.99B | 18.19B | 73.39B | 74.82B |
| High Estimate | 18.57B | 19.21B | 76.54B | 79.93B |
| Year Ago Sales | 18.68B | 17.61B | 73.05B | 75.02B |
| Sales Growth (year/est) | -1.79% | 5.20% | 2.69% | 3.57% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MWZ.F | -- | -- | -- | -- |
| S&P 500 | 12.65% | 2.49% | 7.39% | 14.05% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 5/19/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 5/6/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/11/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/10/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/10/2025 |
| Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 4/9/2025 |